Dna Group (T.R.) Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Erez Navon
Chief executive officer
₪832.0k
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.5% |
Management average tenure | no data |
Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Dna Group (T.R.)'s (TLV:DNA) Earnings Are Built On Soft Foundations
Mar 20Dna Group (T.R.)'s (TLV:DNA) Earnings Might Not Be As Promising As They Seem
Sep 02We Think Dna Group (T.R.) (TLV:DNA) Can Afford To Drive Business Growth
Apr 12Dna Group (T.R.) (TLV:DNA) Is In A Strong Position To Grow Its Business
Jul 07We Think Dna Group (T.R.) (TLV:DNA) Can Easily Afford To Drive Business Growth
Jan 24We're Not Worried About D.N.A Biomedical Solutions' (TLV:DNA) Cash Burn
Oct 07CEO
Erez Navon (50 yo)
less than a year
Tenure
₪832,000
Compensation
Mr. Erez Navon has been the Chairman of the Board at Dna Group (T.R.) Ltd (formerly known as D.N.A Biomedical Solutions Ltd.) from January 6, 2022, CEO from October 6, 2024 and has been its Director since...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 4.2yrs | ₪832.00k | 0.49% ₪ 617.4k | |
Independent External Director | 6.1yrs | no data | no data | |
Director | 3.7yrs | no data | 2.3% ₪ 2.9m |
4.2yrs
Average Tenure
50yo
Average Age
Experienced Board: DNA's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/04/15 22:47 |
End of Day Share Price | 2025/04/15 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dna Group (T.R.) Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.